McKesson (MCK) Expected to Post Earnings on Wednesday

Posted by Stanley Muller on Oct 28th, 2026

McKesson (NYSE:MCK – Get Free Report) is anticipated to issue its Q2 2027 results after the market closes on Wednesday, November 4th. Analysts expect McKesson to post earnings of $10.72 per share and revenue of $109.90 billion for the quarter. McKesson has set its FY 2027 guidance at 44.200-45.000 EPS. Interested persons can find conference call details on the company’s upcoming Q2 2027 earnings summary page for the latest details on the call scheduled for Wednesday, November 4, 2026 at 4:30 PM ET.

McKesson (NYSE:MCK – Get Free Report) last issued its quarterly earnings data on Wednesday, August 5th. The company reported $9.93 EPS for the quarter, beating analysts’ consensus estimates of $9.56 by $0.37. The company had revenue of $105.38 billion for the quarter, compared to analyst estimates of $103.88 billion. During the same period in the prior year, the company posted $8.26 EPS. The business’s revenue was up 7.7% on a year-over-year basis. On average, analysts expect McKesson to post $44.71 EPS for the current fiscal year and $49.99 EPS for the next fiscal year.

McKesson Stock Performance

MCK opened at $967.87 on Wednesday. The business has a 50 day moving average price of $915.13 and a 200 day moving average price of $860.50. McKesson has a twelve month low of $723.68 and a twelve month high of $1,030.27.

McKesson Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, January 4th. Shareholders of record on Tuesday, December 1st will be issued a dividend of $0.94 per share. This represents a $3.76 annualized dividend and a yield of 0.4%. The ex-dividend date is Tuesday, December 1st.

Insiders Place Their Bets

In other news, Director Bradley Lerman sold 301 shares of the company’s stock in a transaction that occurred on Monday, August 10th. The stock was sold at an average price of $892.33, for a total transaction of $268,591.33. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CAO B Jr sold 111 shares of the stock in a transaction that occurred on Tuesday, September 8th. The shares were sold at an average price of $891.45, for a total value of $98,950.95. Following the completion of the sale, the chief accounting officer directly owned 521 shares of the company’s stock, valued at $464,445.45. This represents a 17.56% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 1,212 shares of company stock valued at $1,164,182 in the last three months. Company insiders own 0.06% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on the stock. Leerink Partners lifted their price target on shares of McKesson from $1,030.00 to $1,070.00 and gave the company an “outperform” rating in a research report on Wednesday, October 7th. Robert W. Baird set a $1,015.00 price objective on shares of McKesson in a report on Thursday, August 6th. Barclays raised their target price on shares of McKesson from $925.00 to $1,000.00 and gave the company an “overweight” rating in a research note on Wednesday, August 19th. Evercore reiterated an “outperform” rating and issued a $950.00 target price (down from $1,000.00) on shares of McKesson in a report on Thursday, August 6th. Finally, Royal Bank Of Canada reissued a “sector perform” rating and set a $845.00 target price on shares of McKesson in a research report on Monday, September 14th. Fifteen research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat.com, McKesson currently has a consensus rating of “Moderate Buy” and a consensus price target of $997.12.

Get Our Latest Stock Report on McKesson

About McKesson

(Get Free Report)

McKesson Corporation is a healthcare services and information technology company that distributes pharmaceuticals and medical products to pharmacies, hospitals, health systems, physicians and other healthcare providers. The company also provides technology, data and business solutions designed to support prescription management, pharmacy operations and patient care.

McKesson’s principal activities include pharmaceutical distribution, medical-surgical supply distribution, specialty pharmaceutical services and oncology care support.